McKinsey to pay $78 million in US opioid settlement over its work for drug firms like Purdue Pharma

Consulting firm McKinsey & Co has agreed to pay $78 million to resolve claims by U.S. health insurers and benefit plans that it fueled an epidemic of opioid addiction through its work for drug companies including OxyContin maker Purdue Pharma.